Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage

BackgroundThe peak width of skeletonized mean diffusivity (PSMD) has been proposed as a fully automated imaging marker of relevance to cerebral small vessel disease (SVD). We assessed PSMD in relation to conventional SVD markers, global measures of neurodegeneration, and cognition.Methods145 partici...

Full description

Bibliographic Details
Main Authors: Audrey Low, Elijah Mak, James D. Stefaniak, Maura Malpetti, Nicolas Nicastro, George Savulich, Leonidas Chouliaras, Hugh S. Markus, James B. Rowe, John T. O’Brien
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2020.00238/full
_version_ 1818023685110366208
author Audrey Low
Elijah Mak
James D. Stefaniak
Maura Malpetti
Nicolas Nicastro
Nicolas Nicastro
George Savulich
Leonidas Chouliaras
Hugh S. Markus
James B. Rowe
John T. O’Brien
author_facet Audrey Low
Elijah Mak
James D. Stefaniak
Maura Malpetti
Nicolas Nicastro
Nicolas Nicastro
George Savulich
Leonidas Chouliaras
Hugh S. Markus
James B. Rowe
John T. O’Brien
author_sort Audrey Low
collection DOAJ
description BackgroundThe peak width of skeletonized mean diffusivity (PSMD) has been proposed as a fully automated imaging marker of relevance to cerebral small vessel disease (SVD). We assessed PSMD in relation to conventional SVD markers, global measures of neurodegeneration, and cognition.Methods145 participants underwent 3T brain MRI and cognitive assessment. 112 were patients with mild cognitive impairment, Alzheimer’s disease, progressive supranuclear palsy, dementia with Lewy bodies, or frontotemporal dementia. PSMD, SVD burden [white matter hyperintensities (WMH), enlarged perivascular spaces (EPVS), microbleeds, lacunes], average mean diffusivity (MD), gray matter (GM), white matter (WM), and total intracranial volume were quantified. Robust linear regression was conducted to examine associations between variables. Dominance analysis assessed the relative importance of markers in predicting various outcomes. Regional analyses examined spatial overlap between PSMD and WMH.ResultsPSMD was associated with global and regional SVD measures, especially WMH and microbleeds. Dominance analysis demonstrated that among SVD markers, WMH was the strongest predictor of PSMD. Furthermore, PSMD was more closely associated to WMH than with GM and WM volumes. PSMD was associated with WMH across all regions, and correlations were not significantly stronger in corresponding regions (e.g., frontal PSMD and frontal WMH) compared to non-corresponding regions. PSMD outperformed all four conventional SVD markers and MD in predicting cognition, but was comparable to GM and WM volumes.DiscussionPSMD was robustly associated with established SVD markers. This new measure appears to be a marker of diffuse brain injury, largely due to vascular pathology, and may be a useful and convenient metric of overall cerebrovascular burden.
first_indexed 2024-12-10T03:48:15Z
format Article
id doaj.art-c6db892f90a548be873e9c7ed014c661
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-10T03:48:15Z
publishDate 2020-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-c6db892f90a548be873e9c7ed014c6612022-12-22T02:03:20ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2020-03-011410.3389/fnins.2020.00238506948Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular DamageAudrey Low0Elijah Mak1James D. Stefaniak2Maura Malpetti3Nicolas Nicastro4Nicolas Nicastro5George Savulich6Leonidas Chouliaras7Hugh S. Markus8James B. Rowe9John T. O’Brien10Department of Psychiatry, University of Cambridge, Cambridge, United KingdomDepartment of Psychiatry, University of Cambridge, Cambridge, United KingdomDivision of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United KingdomDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United KingdomDepartment of Psychiatry, University of Cambridge, Cambridge, United KingdomDivision of Neurology, Department of Clinical Neurosciences, Geneva University Hospitals, Geneva, SwitzerlandDepartment of Psychiatry, University of Cambridge, Cambridge, United KingdomDepartment of Psychiatry, University of Cambridge, Cambridge, United KingdomDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United KingdomDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, United KingdomDepartment of Psychiatry, University of Cambridge, Cambridge, United KingdomBackgroundThe peak width of skeletonized mean diffusivity (PSMD) has been proposed as a fully automated imaging marker of relevance to cerebral small vessel disease (SVD). We assessed PSMD in relation to conventional SVD markers, global measures of neurodegeneration, and cognition.Methods145 participants underwent 3T brain MRI and cognitive assessment. 112 were patients with mild cognitive impairment, Alzheimer’s disease, progressive supranuclear palsy, dementia with Lewy bodies, or frontotemporal dementia. PSMD, SVD burden [white matter hyperintensities (WMH), enlarged perivascular spaces (EPVS), microbleeds, lacunes], average mean diffusivity (MD), gray matter (GM), white matter (WM), and total intracranial volume were quantified. Robust linear regression was conducted to examine associations between variables. Dominance analysis assessed the relative importance of markers in predicting various outcomes. Regional analyses examined spatial overlap between PSMD and WMH.ResultsPSMD was associated with global and regional SVD measures, especially WMH and microbleeds. Dominance analysis demonstrated that among SVD markers, WMH was the strongest predictor of PSMD. Furthermore, PSMD was more closely associated to WMH than with GM and WM volumes. PSMD was associated with WMH across all regions, and correlations were not significantly stronger in corresponding regions (e.g., frontal PSMD and frontal WMH) compared to non-corresponding regions. PSMD outperformed all four conventional SVD markers and MD in predicting cognition, but was comparable to GM and WM volumes.DiscussionPSMD was robustly associated with established SVD markers. This new measure appears to be a marker of diffuse brain injury, largely due to vascular pathology, and may be a useful and convenient metric of overall cerebrovascular burden.https://www.frontiersin.org/article/10.3389/fnins.2020.00238/fullsmall vessel diseasemagnetic resonance imagingdiffusion tensor imagingwhite matter hyperintensitiescognitiondementia
spellingShingle Audrey Low
Elijah Mak
James D. Stefaniak
Maura Malpetti
Nicolas Nicastro
Nicolas Nicastro
George Savulich
Leonidas Chouliaras
Hugh S. Markus
James B. Rowe
John T. O’Brien
Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
Frontiers in Neuroscience
small vessel disease
magnetic resonance imaging
diffusion tensor imaging
white matter hyperintensities
cognition
dementia
title Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
title_full Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
title_fullStr Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
title_full_unstemmed Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
title_short Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
title_sort peak width of skeletonized mean diffusivity as a marker of diffuse cerebrovascular damage
topic small vessel disease
magnetic resonance imaging
diffusion tensor imaging
white matter hyperintensities
cognition
dementia
url https://www.frontiersin.org/article/10.3389/fnins.2020.00238/full
work_keys_str_mv AT audreylow peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT elijahmak peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT jamesdstefaniak peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT mauramalpetti peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT nicolasnicastro peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT nicolasnicastro peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT georgesavulich peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT leonidaschouliaras peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT hughsmarkus peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT jamesbrowe peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage
AT johntobrien peakwidthofskeletonizedmeandiffusivityasamarkerofdiffusecerebrovasculardamage